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Abstract
Background: Culture of Mycobacterium tuberculosis is the gold standard method for the laboratory diagnosis of
pulmonary tuberculosis, after effective decontamination.
Results: We evaluated squalamine and chlorhexidine to decontaminate sputum specimens for the culture of
mycobacteria. Eight sputum specimens were artificially infected with 105 colony-forming units (cfu)/mL Mycobacterium
tuberculosis and Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans as contaminants. In the second
step, we tested chlorhexidine-based decontamination on 191 clinical specimens, (Chlorhexidine, 0.1, 0.5 and 0.7 %).
In a last step, growth of contaminants and mycobacteria was measured in 75 consecutive sputum specimens using the
routine NALC-NaOH decontamination protocol or with 0.7 % chlorhexidine decontamination and an inoculation on
Coletsos medium.
In the artificially model, contaminants grew in 100 % of the artificially infected sputum specimens decontaminated
using 100 mg/mL squalamine, in 62.5 % of specimens decontaminated using N-Acetyl-L-Cysteine-Sodium Hydroxide
(NALC-NaOH), and in 0 % of specimens decontaminated using 0.1 %, 0.35 %, or 1 % chlorhexidine (P < 0.05). These
specimens yielded <102 cfuM. tuberculosis using NALC-NaOH and > 1.4.102 cfuM. tuberculosis when any concentration
of chlorhexidine was used (P < 0.05).
In the second step we found that 0.7 %-chlorhexidine yielded 0 % contamination rate, 3.2 % for 0.5 %-chlorhexidine
and 28.3 % for 0.1 %-chlorhexidine. As for the 75 specimens treated in parallel by both methods we found that when
using the standard NALC-NaOH decontamination method, 8/75 (10.7 %) specimens yielded M. tuberculosis colonies
with a time to detection of 17.5 ± 3 days and an 8 % contamination rate. Additionally, 14 specimens yielded
mycobacteria colonies (12M. tuberculosis, and 2 Mycobacterium bolletii) (18.7 %) (P = 0.25), which has yielded a 100 %
sensitivity for the chlorhexidine protocol. Time to detection was of 15.86 ± 4.7 days (P = 0.39) and a 0 % contamination
rate (P < 0.05) using the 0.7 %-chlorhexidine protocol.
Conclusion: In our work we showed for the first time that chlorhexidine based decontamination is superior to
the standard NALC-NaOH method in the isolation of M. tuberculosis from sputum specimens. We currently use
0.7 %-chlorhexidine for the routine decontamination of sputum specimens for the isolation of M. tuberculosis and
non-tuberculosis mycobacteria on egg-lecithin containing media.
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* Correspondence: michel.drancourt@univ-amu.fr
1Aix Marseille Université, URMITE, UM63, CNRS 7278, IRD 198, Inserm 1095,
Institut Hospitalo-Universitaire «Méditerranée Infection», AP-HM, 13005
Marseille, France
2Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes,
Faculté de Médecine, 27, Boulevard Jean Moulin, 13385 Marseille, Cedex 5,
France
© 2015 Asmar and Drancourt. Open Access This article is distributed under the terms of the Creative Commons Attribution
4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Asmar and Drancourt BMC Microbiology  (2015) 15:155 
DOI 10.1186/s12866-015-0479-4
Background
The isolation and culture of Mycobacterium tuberculosis is
the gold standard for laboratory pulmonary tuberculosis
diagnoses, with a yet unsurpassed sensitivity of 100
colony-forming units per milliliter (cfu/mL) [1,2]. M.
tuberculosis can be cultured from respiratory tract and
stool specimens for pulmonary tuberculosis diagnoses
[3,4]. In such specimens, the overgrowth of contaminants,
including Staphylococcus aureus, Pseudomonas aeruginosa
and Candida albicans, hampers the efficient isolation and
culture of M. tuberculosis [5]. Various decontamination
protocols have been proposed to limit the overgrowth of
contaminants, in addition to adding antibiotics and anti-
fungics to the culture media [6]. All of these protocols
were shown to inhibit the viability of M. tuberculosis to
some extent [7]. Sodium chloride (NaOH) -based proto-
cols including the Petroff ’s method and the NALC-NaOH
method, are widely used for decontamination [8,9], despite
the observation that NaOH can also affect M. tuberculosis
viability; it was shown to kill up to 60 % of M. tuberculosis
bacilli in clinical specimens [7]. This may yield false nega-
tive results, especially in paucibacillary infection cases,
such as those observed in HIV-infected patients [10].
Limited data have indicated that a chlorhexidine-based
decontamination protocol, once proposed by our laboratory
[11] and further used to decontaminate sputum [12,13] and
stool specimens [4], performed better than some other
methods for sputum specimen decontamination [11].
However, these studies were limited to the recovery of non-
tuberculosis mycobacteria. Chlorhexidine has not been
thoroughly compared to the reference NaOH protocol
for the laboratory diagnosis of pulmonary tuberculosis.
Additionally, we recently observed that the broad-
spectrum, water-soluble cationic amino-sterol squalamine 1
(7,24-dihydroxylated-24 sulfated cholestane conjugated to
spermidine group at C-3) [14] was ineffective against M.
tuberculosis killing, with a minimum inhibitory concentra-
tion (MIC) >100 mg/L; therefore, it is a promising deconta-
minant [15]. Indeed, squalamine was revealed to have a high
efficiency against gram-positive and gram-negative bacteria,
with particular efficacy against S. aureus (MIC, 3.12 mg/L)
and P. aeruginosa (MIC, 8 mg/L) as well as some activity
against C. albicans (MIC >20 mg/L mg/L) [16]. Therefore,
squalamine has the potential to be incorporated into decon-
tamination protocols for the isolation ofM. tuberculosis.
Here, we assessed various decontamination protocols by
combining various concentrations of chlorhexidine com-
bined with squalamine for the efficient culture of M.
tuberculosis from sputum.
Methods
Artificially infected sputum specimens
Clinical isolates of C. albicans, P. aeruginosa and S. aureus
were calibrated to a final concentration of 107 cfu/mL. Four
M. tuberculosis strains (H37Rv CIP 104475 and three
clinical isolates) were cultured on Coletsos (bioMérieux,
Craponne, France), and the colonies were suspended in
Mycobacteria Growth Indicator Tubes [(MGIT) Becton
Dickinson, Le Pont-de-Claix, France]. The suspensions
were rigorously vortexed using 3-mm sterile glass
beads (Sigma-Aldrich, Saint-Quentin-Fallavier, France)
and bypassed four times through a 25-G needle in
order to disperse any clumped cells. The homogenized
suspensions were then calibrated to 107 cfu/mL by
optical density at 580 nm (Cell Density Meter; Fisher
Scientific, Illkirch, France). Smear-negative sputum speci-
mens that were prospectively collected from our labora-
tory were mixed, sterilized by autoclaving at 121 °C for
15 min and centrifuged at 2500 g for 5 min. The superna-
tants were inoculated with P. aeruginosa, C. albicans and
S. aureus in addition to one of the four different M. tuber-
culosis suspensions in order to achieve a final concentra-
tion of 105 cfu/mL for each microorganism.
The decontamination procedures
For the chlorhexidine or squalamine decontamination
protocols, an equal volume of 0.1 % dithiothreitol (Sigma-
Aldrich) and sputum specimens were mixed together for
10 min in a 50-mL conical tube. Then, a triple volume of
chlorhexidine (0.1, 0.35 or 1 %) (Chlorhexidine digluconate,
Sigma-Aldrich) or squalamine solution were added to yield
a 100 mg/L final concentration. The samples were vortexed
and incubated for 15 min at room temperature with a
continuous agitation. In the cases when inoculations were
conducted on 5 % sheep-blood Columbia agar (COS,
bioMérieux), 10 mL of neutralizing solution [200 mL phos-
phate buffered saline (PBS), 0.6 g egg-lecithin and 2 mL
Tween 80] was added to the chlorhexidine-decontaminated
specimens in order to inactivate the chlorhexidine, and the
mix was vortexed and incubated for 5 min at room
temperature. Next, PBS was added up to 40-mL, the
suspension was centrifuged at 1700 g for 15 min, the super-
natant was discarded, and the pellet was resuspended in
0.5 mL of sterile PBS, pH 6.8. For the squalamine-
chlorhexidine protocol, the squalamine was added first and
mixed followed by incubation for 10 min at room
temperature, and the chlorhexidine was then added. The
reference N-Acetyl-L-Cysteine-Sodium Hydroxide (NALC-
NaOH) method was applied as previously described [9].
A 100-μL volume of specimen decontaminated by chlor-
hexidine at different concentrations (0.1, 0.35 and 1 %),
squalamine-100 μg/mL or chlorhexidine-0.1 %-squalamine-
100 μg/mL and NALC-NaOH and artificially infected
specimens was inoculated in parallel in duplicate on COS
with a non-inoculated negative control to measure the sur-
vival of the contaminants and in triplicate on a modified
Middlebrook 7H10 medium (MOD4), which was previ-
ously described [17], with a non-inoculated negative control
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to compare the M. tuberculosis viability using these differ-
ent protocols. For the contaminants, colonies were ob-
served after 24- and 48-h incubation at 37 °C under a 5 %-
CO2 atmosphere, into an incubator. Contaminant identifi-
cation was confirmed using matrix-assisted laser desorption
ionization-time of flight mass spectrometry (MALDI-TOF-
MS), as previously described [18]. For the M. tuberculosis,
microcolonies were detected on MOD4 by autofluores-
cence, as previously described [17].For each Petri-dish of
the inoculated media, five random autofluorescence
photos were taken on the fifth day of incubation in
microaerophilic atmosphere at 37 °C in order to deter-
mine the mean number of microcolonies that developed
per microscopic field (x 12.5 magnification).
Chlorhexidine decontamination of clinical sputum specimens
The samples used in this study, were sent to the Myco-
bacteria Reference Laboratory (Institut Méditerranée
Infection, Marseille, France) from January to March 2014.
This study has received the agreement of the Ethics
Committee of this Institut on February 19, 2007.
A total of 191 sputum specimens including six Ziehl-
positive specimens collected in 97 patients suspected of
pulmonary tuberculosis, were prospectively decontami-
nated by chlorhexidine to measure the contamination ratio
and recovery of mycobacteria. Based on on-going results, a
total of 53 specimens were decontaminated using 0.1 %-
chlorhexidine, 55 specimens using 0.5 %-chlorhexidine, and
83 specimens using 0.7 %-chlorhexidine.
Furthermore, 75 other sputum specimens were evalu-
ated for decontamination and recovery of mycobacteria by
comparing the routine NALC-NaOH decontamination
protocol and a 0.7 %-chlorhexidine decontamination. A
250 μL-volume of decontaminated specimen was inocu-
lated in a Coletsos tube. The colonies were counted and
identified with Ziehl-Neelsen staining and quantitative
real-time polymerase chain reaction (qPCR), which
targeted the internal transcribed spacer (ITS) by incorpor-
ation of a forward (5'-GGTGGGGTGTGGTGTTTGA
G-3') and a reverse primer (5'-CACGTCCTTCATCGGC
TCTC-3') as well as a M. tuberculosis probe (6FAM-
GCTAGCCGGCAGCGTATCCAT). In the cases when
the qPCR failed, colony identification was accomplished
by standard 16S rRNA gene PCR sequencing, as previ-
ously described [19]. All these experimental procedures
were done by one of us (SA) who has particular expertise
in the field.
Statistical analyses
The Fisher exact test was used to assess the significance
of the differences in the contamination and isolation
rates. The Kruskal-Wallis test was used to assess any
significant differences in the microcolony numbers.
Results
The artificially infected sputum specimens
Using the reference NALC-NaOH protocol, we observed
<7 colonies for any of the contaminants in 5/8 (62.5 %)
inoculated COS medium plates. These contaminants were
identified as C. albicans and P. aeruginosa by MALDI-
TOF-MS. Using squalamine, we observed an uncountable
number of colonies, which were identified as S. aureus, P.
aeruginosa and C. albicans in 8/8 (100 %) specimens
(P < 0.05). Using 1 %, 0.35 %, and 0.1 % chlorhexidine and
0.1 % - chlorhexidine/100 mg/L - squalamine, we observed
no growing contaminants (0 %) (P = 0.026, Fisher exact
test). For the four M. tuberculosis strains, the mean
microcolony number that was detected per field resulting
from the different decontamination methods are presented
in Table 1. There was a significant difference in the
M. tuberculosis colony number between the different
chlorhexidine-based protocols and the reference NALC-
NaOH method (P < 0.05). The difference in the M. tuber-
culosis colony number between the 0.1 %-chlorhexidine
treatment and the other chlorhexidine concentrations was
significant (P < 0.05). The difference between the 0.35 %-
chlorhexidine and 1 %-chlorhexidine treatments as well as
between the 0.1 %-chlorhexidine and 0.1 %-chlorhexidine/
100 μg/ml-squalamine treatments was not statistically
significant (P > 0.05).
The clinical specimens
The rate of contamination was respectively 28.3 % (15/53),
3.2 % (2/55) and 0 % for 0.1 %-chlorhexidine, 0.5 %-chlor-
hexidine (P < 0.05) and 0.7 %-chlorhexidine (P < 0.05),
respectively. Contaminants were identified as S. aureus (2)
and Streptococcus spp. (13). Specimens decontaminated by
0.1 %-chlorhexidine yielded three M. tuberculosis isolates,
with a mean time to detection of 14.67 ± 5.1 days (9–19).
Nine mycobacteria were cultured from specimens treated
by 0.7 %-chlorhexidine, including 7 M. tuberculosis isolates
and 2M. avium isolates, with a 23 ± 4.6 days (17–30) mean
time to detection (P < 0.05).
As for the 75 sputum specimens treated in parallel by the
reference method and 0.7 %-chlorhexidine, NALC-NaOH
decontamination yielded eight (10.7 %) M. tuberculosis
isolates, which grew on Coletsos medium, with a mean
time to detection of 17.5 ± 3 days (15–23 days) and an 8 %
contamination rate. The contaminants were identified as
Candida orthopsilosis (1), Candida glabrata (1), Streptococ-
cus oralis (2), Hafnia alvei (1) and Raoultella ornithinoly-
tica (1). Using a 0.7 %-chlorhexidine decontamination
treatment, 14 mycobacteria (12M. tuberculosis and 2 Myco-
bacterium bolletii) (18.7 %) isolates were observed (P =
0.25), with a 100 % sensitivity for Mycobacterium isolation
when the NALC-NaOH is considered as the reference
method with a mean time to detection of 15.85 ± 4.7 days
(8–25 days) (P = 0.39) for all mycobacteria and 17.33 ±
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3.08 days (14–25 days) for the M. tuberculosis colonies (P
= 0.9) and 0 % contamination (P < 0.05). All of the M. tu-
berculosis isolates that were observed using the NALC-
NaOH decontamination method were also isolated with
0.7 %-chlorhexidine (Table 2). The number of M. tubercu-
losis colonies that were cultured using the 0.7 %-chlorhexi-
dine decontamination method (8, 47, 52, 83, >100, >100,
>100 and >100 colonies) was higher than those grown after
the NALC-NaOH treatment (12, 7, 8, 31, 13, 17, 66 and
>100 colonies) (Table 3, Fig. 1).
Discussion
The routine NALC-NaOH decontamination method for
sputum specimens does not prevent all contaminations, as
a 2–5 % ratio of contamination is routinely observed [20],
some works reported higher contamination rate on LJ (10–
14 %) [21–23]. Here, we used artificially contaminated spu-
tum in a first step to assess the efficacy of decontamination.
Accordingly, a 8 % contamination rate may be due to the
fact that we incorporated several specimens from the same
cystic fibrosis patients (13.3 %) which are usually contami-
nated with resistant flora [24]. Additionally, this protocol is
known to alter the viability ofM. tuberculosis in decontami-
nated sputum, as observed in this study [12]. We therefore
compared alternative decontamination protocols.
Based on its reported activity against contaminants [16]
and its lack of activity against mycobacteria, including M.
tuberculosis [15], squalamine was a potential candidate for
decontamination. However, our investigation evaluating
artificially infected sputum specimens indicated that
100 mg/L squalamine did not eliminate contaminant
bacteria. This observation contrasts with the observation
that only C. albicans resists to 100 mg/mL squalamine (not
published data). This agree with a previously published re-
port that showed a MIC of chlorhexidine of >20 mg/L [16].
These data suggest that sputum may contain interfering
factors that further limit the activity of squalamine against
P. aeruginosa and S. aureus.
Chlorhexidine was more effective than the routine
NALC-NaOH protocol in decontaminating artificially
Table 1 Mean, median and standard deviation in the number
of M. tuberculosis microcolonies, after decontamination of
artificially infected sputum samples
M. tuberculosis H37Rv CIP 104475 Mean Median Standard
variation
chlorhexidine −0.1 % 844.4 736.5 361
chlorhexidine −0.1 % -
squalamine 100 μg/mL
1288 1396 576.3
chlorhexidine −0.35 % 477.1 453 154.5
chlorhexidine −1 % 665 630 207.6
NALC-NaOH 71.9 66 58.8
M. tuberculosis clinical isolate 1 Mean Median Standard
variation
chlorhexidine-0.1 % 2493.1 2624.5 553.2
chlorhexidine-0.1 % -
squalamine 100 μg/mL
1774.5 1309 498.2
chlorhexidine −0.35 % 1259.6 1238.5 393.1
chlorhexidine −1 % 1426.6 1434 357.5
NALC-NaOH 81.7 73 37.3
M. tuberculosis clinical isolate 2 Mean Median Standard
variation
chlorhexidine-0.1 % 556.1 621 155.9
chlorhexidine-0.1 % -
squalamine 100 μg/mL
440.4 433 134.6
chlorhexidine −0.35 % 237.9 202 127.4
chlorhexidine −1 % 184.7 180 50.7
NALC-NaOH 4.4 4 2.83
M. tuberculosis clinical isolate 3 Mean Median Standard
variation
chlorhexidine-0.1 % 288.1 284.5 87.8
chlorhexidine-0.1 % -
squalamine 100 μg/mL
124.4 136 26.1
chlorhexidine −0.35 % 174.9 194 76.5
chlorhexidine −1 % 140.7 142.5 25.5
NALC-NaOH 4.9 3 3.7
Table 2 Yield of mycobacteria and contaminants in 75 sputum samples, decontaminated by 0.7 %-chlorhexidine or NALC-NaOH
NALC-NaOH
Positive M.
tuberculosis
Positive other
mycobacteria
Contaminated/
Positive
Contaminated/
Negative
Negative Total
Chlorhexidine-
0.7 %
Positive M. tuberculosis 7 0 1 2 2 12
Positive other
mycobacteria
0 0 0 0 2 2
Contaminated/Positive 0 0 0 0 0 0
Contaminated/
Negative
0 0 0 0 0 0
Negative 0 0 0 3 58 61
Total 7 0 1 5 62 75
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infected and clinical sputum specimens at a 0.1, 0.35 and
1 % concentration in replicate. Moreover, it yielded 10–100
more M. tuberculosis colonies than the standard NALC-
NaOH method in triplicates, in agreement with previously
published data regarding growth of non-tuberculosis
mycobacteria on Löwenstein-Jensen medium [12,13].
Contrarily to the results obtained previously, we
observed that a 0.1 %-chlorhexidine concentration and a
100 mg/mL squalamine are ineffective for the decontam-
ination of sputum (28.3 % contamination rate). There-
fore, we increased the concentration of chlorhexidine
and found that a 0.7 %-chlorhexidine was optimal for a
routine use.
We therefore used an optimized 0.7 % chlorhexidine
decontamination method for clinical sputum specimens
and observed that this protocol yielded a non-significant,
nevertheless, higher mycobacteria isolate number than the
routine NALC-NaOH decontamination method (14
versus 8 isolates in 75 sputum specimens). Moreover, a
higher M. tuberculosis colony number was also observed,
which is in agreement with the results obtained in the arti-
ficial model. These observations extended to M. tubercu-
losis and any sputum specimen, which is in line with
observations previously made for non-tuberculosis myco-
bacteria isolated from cystic fibrosis sputum [12,13]. It
must be emphasized that chlorhexidine, which is poten-
tially toxic for mycobacteria, must be inactivated by
incorporation with egg-lecithin in the culture medium.
Table 3 Number of M. tuberculosis colonies for the eight
positive cultures on Coletsos medium in both 0.7 %
chlorhexidine and NALC-NaOH decontamination
Number of M. tuberculosis colonies detected
Specimen 0.7 % Chlorhexidine NALC-NaOH
1 8 12
2 47 7
3 52 8
4 83 31
5 >100 13
6 >100 17 (+contamination)
7 >100 66
8 >100 >100
Fig. 1 An illustration of the number of mycobacteria colonies developed on Coletsos medium after decontamination by 0.7 %-chlorhexidine or
NALC-NaOH (1, 2, 3, 4, 5 and 6 represent M. tuberculosis isolates, 7 and 8 represent M. bolletii isolates)
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Conclusions
Here, we observed that a chlorhexidine-based decontam-
ination method is effective against contaminants and more
appropriate for the viability of mycobacteria. Moreover,
we observed for the first time that routine chlorhexidine-
based decontamination on specimens including those re-
ceived from cystic fibrosis patients yielded superior results
for the isolation, in particularly of M. tuberculosis than the
standard NALC-NaOH decontamination method. At last,
our preliminary cost evaluation based on 1000 specimens,
indicates a 0.31 €/specimen cost of chlorhexidine lower
than to the 1.4 €/specimen cost of reference NALC-
NaOH decontamination. These tabulations do not take
into consideration the short 24-h expire delay for NALC-
NaOH; when chlorhexidine can be stored for 3 months at
room temperature.
We currently use a 0.7 % chlorhexidine decontamin-
ation protocol combined with cultures on an egg-based
medium [17] in our routine practice.
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